Varex Imaging (VREX) Competitors

Varex Imaging (NASDAQ:VREX) and Evolus (NASDAQ:EOLS) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their community ranking, analyst recommendations, valuation, profitability, media sentiment, risk, dividends, earnings and institutional ownership.

Which has preferable earnings & valuation, VREX or EOLS?

Varex Imaging has higher revenue and earnings than Evolus. Evolus is trading at a lower price-to-earnings ratio than Varex Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Varex Imaging	$893.40M	0.77	$48.20M	$0.96	17.61
Evolus	$202.09M	3.34	-$61.69M	-$1.09	-10.68

Do insiders & institutionals believe in VREX or EOLS?

90.7% of Evolus shares are owned by institutional investors. 5.2% of Varex Imaging shares are owned by insiders. Comparatively, 5.4% of Evolus shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Is VREX or EOLS more profitable?

Varex Imaging has a net margin of 5.08% compared to Evolus' net margin of -30.52%. Varex Imaging's return on equity of 9.21% beat Evolus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Varex Imaging	5.08%	9.21%	4.22%
Evolus	-30.52%	N/A	-32.19%

Do analysts recommend VREX or EOLS?

Varex Imaging presently has a consensus price target of $27.00, suggesting a potential upside of 59.67%. Evolus has a consensus price target of $20.60, suggesting a potential upside of 76.98%. Given Evolus' higher possible upside, analysts plainly believe Evolus is more favorable than Varex Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Varex Imaging	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Evolus	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the MarketBeat Community prefer VREX or EOLS?

Evolus received 108 more outperform votes than Varex Imaging when rated by MarketBeat users. Likewise, 71.82% of users gave Evolus an outperform vote while only 63.64% of users gave Varex Imaging an outperform vote.

Company	Underperform	Outperform
Varex Imaging	Outperform Votes 231 63.64%	Underperform Votes 132 36.36%
Evolus	Outperform Votes 339 71.82%	Underperform Votes 133 28.18%

Which has more volatility & risk, VREX or EOLS?

Varex Imaging has a beta of 0.69, indicating that its share price is 31% less volatile than the S&P 500. Comparatively, Evolus has a beta of 1.45, indicating that its share price is 45% more volatile than the S&P 500.

Does the media refer more to VREX or EOLS?

In the previous week, Evolus had 6 more articles in the media than Varex Imaging. MarketBeat recorded 7 mentions for Evolus and 1 mentions for Varex Imaging. Evolus' average media sentiment score of 0.75 beat Varex Imaging's score of -0.99 indicating that Evolus is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Varex Imaging	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative
Evolus	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Evolus beats Varex Imaging on 10 of the 17 factors compared between the two stocks.